Dr. Howard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
81 Highland Springs Avenue
Suite 201
Beaumont, CA 92223Phone+1 951-558-2262Fax+1 951-849-3877
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1987 - 1990- Brigham and Women's HospitalResidency, Internal Medicine, 1985 - 1987
Harvard Medical SchoolClass of 1985
Certifications & Licensure
CA State Medical License 1995 - 2023
MD State Medical License 1993 - 2000
Clinical Trials
- Dabrafenib and Trametinib for the Treatment of Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2014 Sep 19
Publications & Presentations
PubMed
- 58 citationsThe CD3 zeta cytoplasmic domain mediates CD2-induced T cell activation.Frank D. Howard, Philippe Moingeon, Ulrich Moebius, David J. McConkey, Booma D. Yandava
The Journal of Experimental Medicine. 1992-07-01 - 44 citationsAn in vitro line of the B cell tumor BCL1 can be activated by LPS to secrete IgM1.Eva Severinson Gronowicz, Carol Doss, Frank D. Howard, David C. Morrison
Journal of Immunology. 1980-09-01 - 34 citationsClinico-pathologic relevance of Survivin splice variant expression in cancerRosalia de Necochea-Campion, Chien-Shing Chen, Saied Mirshahidi, Frank D. Howard, Nathan R. Wall
Cancer Letters. 2013-10-10
Press Mentions
WhyWeVax™ Announces Expansion of Board of Directors with Eight New MembersSeptember 25th, 2020
Football’s Last Taboos: Part 5 - We Need a Discussion About ConcussionOctober 18th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
